ASTELLAS PHARMA US, INC.

Lobbying client · Illinois · filed 2025 to 2026

$4,160,000 Reported spend

6 Filings counted

1 Firms hired

4 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (188248), not by name.

Firms hired 1

ASTELLAS PHARMA US, INC. $4,160,000 6 filings

Bills named in these filings 4

HR 1300
PSA Screening for HIM Act

6 filings
S 297
PSA Screening for HIM Act

6 filings
HR 5376
Impacts and Outcomes for Health Career Training Act

1 filing
S 392
Sloan Canyon Conservation and Lateral Pipeline Act

1 filing

Reported by year 2 years

2026 $1,100,000 2 filings
2025 $3,060,000 4 filings

Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

Centers For Medicare and Medicaid Services (CMS) 6
HOUSE OF REPRESENTATIVES 6
Natl Institutes of Health (NIH) 6
SENATE 6

Recent filings 6 total

Q2

ASTELLAS PHARMA US, INC.

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $510,000 expenses · posted Jul 20, 2026

View → Q1

ASTELLAS PHARMA US, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $590,000 expenses · posted Apr 20, 2026

View → Q4

ASTELLAS PHARMA US, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $980,000 expenses · posted Jan 20, 2026

View → Q3

ASTELLAS PHARMA US, INC.

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $850,000 expenses · posted Oct 20, 2025

View → Q2

ASTELLAS PHARMA US, INC.

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $670,000 expenses · posted Jul 21, 2025

View → Q1

ASTELLAS PHARMA US, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $560,000 expenses · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.